This interaction results in the stiffening of TRCs and enables perforin to penetrate the cell membrane, facilitating CTL-mediated killing of TRCs and promoting tumor immunotherapy (Liu Y. et al., 2021). This evidence concerns the gene PRF1 and neoplasm.